Next Article in Journal
Pathological and Molecular Features of Nodal Peripheral T-Cell Lymphomas
Next Article in Special Issue
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients
Previous Article in Journal
Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa
Previous Article in Special Issue
Rapid SARS-CoV-2 Virus Enrichment and RNA Extraction for Efficient Diagnostic Screening of Pooled Nasopharyngeal or Saliva Samples for Dilutions Up to 1:100
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Tularemia Presenting Solely with Cervical Lymphadenopathy and Fever

by
Göran Ramin Boeckel
1,2,*,
Jan Basri Adiprasito
2,
Neele Judith Froböse
3,
Frieder Schaumburg
3,
Richard Vollenberg
2 and
Phil-Robin Tepasse
2,*
1
Department of Medicine D for Nephrology and Rheumatology, University Hospital Muenster, 48149 Muenster, Germany
2
Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany
3
Institute of Medical Microbiology, University of Muenster, Domagkstraße 10, 48149 Muenster, Germany
*
Authors to whom correspondence should be addressed.
Diagnostics 2022, 12(8), 2000; https://doi.org/10.3390/diagnostics12082000
Submission received: 19 July 2022 / Revised: 12 August 2022 / Accepted: 16 August 2022 / Published: 18 August 2022
(This article belongs to the Special Issue Molecular Diagnostics of Emerging Pathogens for Infectious Diseases)

Abstract

:
A 52-year-old German female presented with cervical lymphadenopathy and fever. Despite the initial symptom-presentation leading to the consideration of sarcoidosis, lymphoma, tuberculosis, and toxoplasmosis, an extensive serologic and histo- and molecular pathologic workup eventually indicated a likely diagnosis of tularemia. This case brings to light that tularemia is a diagnostic challenge and requires high reliance on the epidemiological context thorough patient history, and an extensive interdisciplinary diagnostic workup.

1. Introduction

The Gram-negative coccobacillus Francisella tularensis causes the zoonosis tularemia [1,2]. Five subspecies exist of this pathogen, of which F. tularensis subsp. tularensis (called F. tularensis type A) and F. tularensis subsp. holarctica (called F. tularensis type B) cause infections in humans. The occurrence of F. tularensis covers much of the Northern Hemisphere; type A is common in North America, while type B is distributed in Europe and Asia [3]. The highest incidences of tularemia have been reported in Sweden, Finland, and Turkey [4]. In Germany, tularemia is a rare disease with an estimated incidence of 0.03 cases per 100,000 people per year [5].
Among others, the synonyms of tularemia include Francis disease, deer-fly fever, and rabbit fever. Tularemia presents with a wide range of clinical manifestations, from asymptomatic courses of disease to septic shock and death within weeks. The infection usually occurs after skin or mucosal contact with (the materials of) infected animals, or through invertebrate vectors (e.g., mosquitos and/or ticks), the inhalation of contaminated dust, or contaminated food (e.g., undercooked meat, must) and water [5,6,7]. Depending on the clinical expression, six manifestations of the disease (potentially overlapping) are distinguished: ulceroglandular, glandular, oculoglandular, pharyngeal, pneumonic, and typhoidal tularemia [8]. Within three weeks following pathogen exposure (a median of 3–5 days), patients present with non-specific, abrupt symptoms such as fever, fatigue, anorexia, headache, abdominal pain, emesis, or diarrhea [9].
The most common manifestation (ulceroglandular disease) usually presents with fever, lymphadenopathy, and a single erythematous skin lesion.
After direct pathogen-inhalation, pneumonic disease may present with a non-productive cough, peribronchial infiltrates, and/or pleural effusion.
Glandular tularemia displays without characteristic skin lesions and is found more often in children than in adults [10].
Especially due to the unspecific initial symptoms and the high reliance on the epidemiological context, tularemia is considered to be underdiagnosed [5,11]. Treatment mostly consists of antibiotic therapy. Streptomycin and gentamicin seem to be most effective; however, due to the better side-effect profile, quinolones (e.g., ciprofloxacin) and tetracyclines (e.g., doxycycline) appear to be an effective therapeutic alternative [12,13].
Here, we present the case of an adult woman with solely lymph node swelling and fever. Despite the initial concern about several differential diagnoses including tuberculosis, lymphoma, and toxoplasmosis, a thorough patient history, as well as an extensive interdisciplinary diagnostic workup, eventually revealed tularemia.

2. Case Presentation

A 52-year-old female was transferred to our tertiary care hospital for further evaluation of cervical lymph node swelling and suspicion of tuberculosis.
Two months prior to presentation at our hospital, the patient had been admitted to another hospital because of fatigue and fever. She had received antibiotic treatment with a cephalosporin (cefaclor) as well as ciprofloxacin from her general practitioner, without symptom alleviation. A diagnosis of sarcoidosis with lung affection (Table 1) had been considered; however, there were no conclusive radiological findings.
Because of the progressive cervical lymph node swelling (Figure 1A), the case had been presented to otolaryngology and a CT scan of the neck was performed. The findings showed centrally fused space-occupying processes on the left neck with additional left-sided enlarged and increased lymph nodes in the remaining cervical-to-supraclavicular stations, primarily classified as malignancy-suspicious (Table 1).
A panendoscopy with cervical lymph node extraction was performed. Histology found no signs of malignancy, but found scattered multinucleated giant cells. Despite negative Ziehl–Neelsen staining, tuberculosis (TBC) was still considered a likely diagnosis based on the pathology. Therefore, further molecular diagnostics were initiated (Table 1), which did not reveal any conclusive findings.
An additional radiological analysis (CT scan chest/abdomen) showed no signs of primary tumors or metastases. However, isolated granulomas in the left lower lung were described. Postoperatively, the cervical wounds showed prolonged secretion and painful surrounding edema (Figure 1B). The patient was ultimately released with oral antibiotics (amoxicillin/clavulanic acid), and a recommendation for further evaluation at our infectious diseases department was made.
Upon presentation at our hospital, the only remaining symptom was cervical lymph node swelling. The last time B-symptoms (fever, night sweats, weight loss) had occurred had been two months before presentation. The patient presented with normal vegetative status without any signs of infection. An extended patient history revealed that she was a never-smoker and rarely consumed alcohol. She was born in Poland and moved to Germany 40 years ago. She was the mother of three children and lived with her mother-in-law and her husband. Her occupation was as a cook and her last vacation abroad had been to Poland two years prior to her symptom onset. The patient had cats as pets.
Physical examination showed equal pupils with a normal reaction to light and no alopecia. The dental status was regular with rosy, moist oral mucosa, no plaque, no lesions, and no petechiae. The heart and lungs were normal upon auscultation. The abdominal wall was soft, the liver and spleen were not enlarged and palpable, with no resistance. The left cervical lymph nodes showed persistent lymphadenopathy with scaring tissue (after biopsy); there was no palpable peripheral lymphadenopathy of the clavicular, axillary, or inguinal region. The joints were freely mobile, without edema. The skin showed signs of erythema/exanthema without signs of bleeding. There was no evidence of a focal neurological deficit.
The standard laboratory analyses were unremarkable with minor normochromic anemia (10.8 g/dL (normal range: 11.9–14.6 g/dL)) and minor LDH elevation (290 U/L (normal range: 135–214 U/L)). Screening tests for HIV and Hepatitis B and C were negative.
An evaluation of external radiological scans in our department provided no additional insights.
An interferon-gamma release assay (Table 1) was used to test for exposure to Mycobacterium tuberculosis complex and showed a negative result. Because of the pets, a differential diagnosis of toxoplasmosis (Table 1) or bartonellosis (Table 1) was considered. The findings were consistent with latent toxoplasmosis (toxoplasma-IgG 147 IU/mL (normal range: <10 IU/mL); IgM negative) and a negative bartonellosis serology was found.
After new swelling at the operation site due to abscesses, needle aspiration was performed and new bioptic material was obtained. For bacterial cultures, Columbia blood agar, chocolate agar and Schaedler KV agar were incubated (Table 1). As the culture remained without pathogen detection, a broad molecular diagnostic was initiated. This included diagnostics for tuberculosis, atypical mycobacteria, Bartonella henselae, Cryptococcus neoformans/Cryptococcus gattii, Aspergillus sp. And other fungi, Chlamydia trachomatis, and Brucella sp., as well as a PCR diagnostic, which detects pathogens of the (eu-) bacteria domain by means of standard in-house PCR with amplicon detection in agarose gel [14] (Table 1). F. tularensis subsp. holarctica was thereby identified via 16S RNA gene sequence comparison (GenBank accession no. CP044005.1, identity 99.72%; Table 1). All the other tests showed negative results. The DNA and associated native material were subsequently sent to the tularemia consulting laboratory in Berlin, Germany, where the molecular result was confirmed, but cultivation was not successful. Serological testing for tularemia was sent to the Bernhard Nocht Institute for Tropical Medicine (Hamburg) and showed positive results (Ig ELISA; IgG Blot; no further quantification).
In another in-depth patient history, the patient reported buying venison from a hunter on a regular basis. Most recently, in the month prior to the onset of symptoms, she had consumed venison that she had purchased from the local hunter approximately one year earlier and had stored in a frozen state until consumption. As she was the only one to touch the uncooked meat, none of the relatives who ate the cooked meat became sick. Unfortunately, no frozen samples of the suspected meat were left over for examination. Therapy with ciprofloxacin twice daily for 3 weeks was initiated.
Upon follow-up at our outpatient clinic after completion of the treatment, the left cervical operation site had improved significantly, with distinct sonographic regression of the lymphadenopathy (Figure 1C). Five months after the initial symptom onset, the patient reported being well and free of symptoms.

3. Discussion

The previously described nonspecific clinical presentation of tularemia simplifies the misdiagnosis due to the multitude of differential diagnoses. Regarding the nonspecific lymphadenopathy, numerous differential diagnoses, such as, among others, streptococcal or staphylococcal infections, brucellosis, bartonellosis, sporotrichosis, Pasteurella multocida infections, and parotitis in mumps, should be considered [15].
Furthermore, symptoms consisting of fever and a general feeling of illness in combination with regional lymph node swelling may indicate lymphoma [16].
Granuloma-like changes in the lungs, in particular, can point toward tuberculosis [17]. Other pulmonary diseases may also present with a similar clinical picture. These include abscessing pneumonia, but also mycoplasma pneumonia, pneumonic plague, or mycoses [15]. The most important differential diagnoses and the possibilities of differentiation are listed in Table 1.
In general, the blood count and laboratory chemistry, if any, show nonspecific changes such as moderate leukocytosis or CRP elevation at the onset of the disease. Furthermore, mildly elevated levels of lactate dehydrogenase (LDH), alkaline phosphatase (AP), and serum transaminases are possible. Furthermore, patients may present with myoglobinuria as well as pyuria, which may be falsely diagnosed as a urinary tract infection. Rhabdomyolysis with elevated serum creatinine kinase levels has also been described in some patients [15,18,19].
Patients with lymphadenopathy and nonspecific symptoms should also be examined for tularemia if they have a history of potential exposure. Furthermore, patients with suspected tuberculous lung disease or a granulomatous disease should also be considered for tularemia, especially if infection with mycobacteria is excluded [17].
The diagnosis itself is mainly made via molecular methods. Obtaining a culture requires containment level 3, and is therefore (in Germany) reserved for specialized laboratories; the fastidious pathogen grows on cysteine-containing solid culture media (blood or chocolate agar) at 37 °C under aerobic conditions [20,21].
Another possibility for direct pathogen detection is the detection of DNA via PCR analysis. Data from 2008 showed increased sensitivity in PCR diagnostics compared to cultural detection of the pathogen [22].
Serology is the third pillar of the diagnosis of Francisella tularensis infections. A titer of more than 1:160 or a 4-fold increase in the titer in successive samples has diagnostic value. The advantage of serological testing, however, is the comparatively simple procedure and the low number of false-negative results [23]. However, cross-reactions, especially with Brucella and Yersinia species, must be mentioned, as these can lead to false-positive results [24].
In the context of cervical lymphadenopathy, cytology after fine-needle aspiration is also considered to have a potential diagnostic role in addition to serology, PCR, and culture [25]. Furthermore, flow cytometric assays looking at the relative number of CD3+/CD4−/CD8− T cells could play a role in the early diagnosis of tularemia. These assays showed elevated levels 7 days before a serological diagnosis was possible [26].

4. Conclusions

The diagnosis of tularemia is an iterative process due to the rarity of the disease and the non-specific symptoms. Regarding patient history, it is important to pay attention to the patient’s origin from areas with a high incidence of tularemia, as well as to the fact that the patient belongs to a population group that has contact with wild animals or their processing, and therefore, has an increased probability of exposure.
This case report demonstrates the relevance of broad molecular diagnostics in unclear infectious cases. Evidence of the pathogen was provided via 16S RNA gene sequencing in a case where cultural cultivation was no longer possible.
A broad interdisciplinary diagnostic approach by clinicians and in microbiology, pathology, and radiology is essential.

Author Contributions

Conceptualization, G.R.B. and P.-R.T.; methodology, G.R.B., N.J.F. and J.B.A.; validation, N.J.F., R.V., F.S. and P.-R.T.; formal analysis, G.R.B., N.J.F. and J.B.A.; data curation, G.R.B., N.J.F. and J.B.A.; writing—original draft preparation, G.R.B. and N.J.F.; writing—review and editing, all authors; visualization, G.R.B., N.J.F., J.B.A. and R.V.; supervision, P.-R.T.; project administration, G.R.B. and P.-R.T.; funding acquisition, P.-R.T. All authors have read and agreed to the published version of the manuscript.

Funding

The APC for this Article was funded by the Open Access Publication Fund of the University of Muenster.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Informed consent was obtained from the patient.

Data Availability Statement

Not applicable.

Acknowledgments

We are grateful for the support from the Center for Biological Hazards and Special Pathogens of the Robert Koch Institute, Berlin, and from Bernhard Nocht Institute of Tropical Medicine, Hamburg.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ellis, J.; Oyston, P.C.; Green, M.; Titball, R.W. Tularemia. Clin. Microbiol. Rev. 2002, 15, 631–646. [Google Scholar] [CrossRef] [PubMed]
  2. Snowden, J.; Simonsen, K.A. Tularemia. In StatPearls; StatPearls Publishing LLC.: Treasure Island, FL, USA, 2022. [Google Scholar]
  3. McLendon, M.K.; Apicella, M.A.; Allen, L.A. Francisella tularensis: Taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annu. Rev. Microbiol. 2006, 60, 167–185. [Google Scholar] [CrossRef] [PubMed]
  4. Desvars, A.; Furberg, M.; Hjertqvist, M.; Vidman, L.; Sjöstedt, A.; Rydén, P.; Johansson, A. Epidemiology and ecology of tularemia in Sweden, 1984-2012. Emerg. Infect. Dis. 2015, 21, 32–39. [Google Scholar] [CrossRef] [PubMed]
  5. Faber, M.; Heuner, K.; Jacob, D.; Grunow, R. Tularemia in Germany—A Re-emerging Zoonosis. Front. Cell. Infect. Microbiol. 2018, 8, 40. [Google Scholar] [CrossRef]
  6. Jacob, D.; Köppen, K.; Radonić, A.; Haldemann, B.; Zanger, P.; Heuner, K.; Grunow, R. Molecular identification of the source of an uncommon tularaemia outbreak, Germany, autumn 2016. Eurosurveillance 2019, 24, 1800419. [Google Scholar] [CrossRef] [PubMed]
  7. Abdellahoum, Z.; Maurin, M.; Bitam, I. Tularemia as a Mosquito-Borne Disease. Microorganisms 2020, 9, 26. [Google Scholar] [CrossRef]
  8. Evans, M.E.; Gregory, D.W.; Schaffner, W.; McGee, Z.A. Tularemia: A 30-year experience with 88 cases. Medicine 1985, 64, 251–269. [Google Scholar] [CrossRef]
  9. Penn, R.L. Francisella tularensis (Tularemia). In Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th ed.; Bennett, J.E., Dolin, R., Blaser, M.J., Eds.; Churchill Livingstone: Philadelphia, PA, USA, 2014; pp. 2590–2602. [Google Scholar]
  10. Jacobs, R.F.; Condrey, Y.M.; Yamauchi, T. Tularemia in adults and children: A changing presentation. Pediatrics 1985, 76, 818–822. [Google Scholar] [CrossRef]
  11. Yeni, D.K.; Büyük, F.; Ashraf, A.; Shah, M. Tularemia: A re-emerging tick-borne infectious disease. Folia Microbiol. 2021, 66, 1–14. [Google Scholar] [CrossRef]
  12. Caspar, Y.; Maurin, M. Francisella tularensis Susceptibility to Antibiotics: A Comprehensive Review of the Data Obtained In Vitro and in Animal Models. Front. Cell. Infect. Microbiol. 2017, 7, 122. [Google Scholar] [CrossRef]
  13. STAKOB, R. Hinweise zur Therapie der Tularämie. 2021. Available online: https://edoc.rki.de/handle/176904/8865 (accessed on 1 July 2022).
  14. Becker, K.; Harmsen, D.; Mellmann, A.; Meier, C.; Schumann, P.; Peters, G.; von Eiff, C. Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J. Clin. Microbiol. 2004, 42, 4988–4995. [Google Scholar] [CrossRef] [PubMed]
  15. Grunow, R.; Splettstösser, W.; Hirsch, F.W.; Kleemann, D.; Finke, E.J. Differential diagnosis of tularemia. DMW-Dtsch. Med. Wochenschr. 2001, 126, 408–413. [Google Scholar] [CrossRef] [PubMed]
  16. Tärnvik, A.; Berglund, L. Tularaemia. Eur. Respir. J. 2003, 21, 361–373. [Google Scholar] [CrossRef] [PubMed]
  17. Karabay, O.; Kilic, S.; Gurcan, S.; Pelitli, T.; Karadenizli, A.; Bozkurt, H.; Bostanci, S. Cervical lymphadenitis: Tuberculosis or tularaemia? Clin. Microbiol. Infect. 2013, 19, E113–E117. [Google Scholar] [CrossRef] [PubMed]
  18. Kaiser, A.B.; Rieves, D.; Price, A.H.; Gelfand, M.R.; Parrish, R.E.; Decker, M.D.; Evans, M.E. Tularemia and rhabdomyolysis. JAMA 1985, 253, 241–243. [Google Scholar] [CrossRef]
  19. Kubiliute, I.; Zablockiene, B.; Paulauskiene, R.; Navickas, G.; Jancoriene, L. A Rare Case of Tularemia Complicated by Rhabdomyolysis with a Successful Outcome. Medicina 2021, 57, 449. [Google Scholar] [CrossRef]
  20. Oyston, P.C.F. Francisella tularensis: Unravelling the secrets of an intracellular pathogen. J. Med. Microbiol. 2008, 57, 921–930. [Google Scholar] [CrossRef]
  21. Robert Koch-Institut. Tularämie. RKI-Ratgeber 2016. Available online: https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/merkblaetter_node.html (accessed on 1 July 2022).
  22. Johansson, A.; Berglund, L.; Eriksson, U.; Göransson, I.; Wollin, R.; Forsman, M.; Tärnvik, A.; Sjöstedt, A. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J. Clin. Microbiol. 2000, 38, 22–26. [Google Scholar] [CrossRef]
  23. Hepburn, M.J.; Simpson, A.J. Tularemia: Current diagnosis and treatment options. Expert Rev. Anti-Infect. Ther. 2008, 6, 231–240. [Google Scholar] [CrossRef]
  24. Maurin, M. Francisella tularensis, Tularemia and Serological Diagnosis. Front. Cell. Infect. Microbiol. 2020, 10, 512090. [Google Scholar] [CrossRef]
  25. Tuncer, E.; Onal, B.; Simsek, G.; Elagoz, S.; Sahpaz, A.; Kilic, S.; Altuntas, E.E.; Ulu Kilic, A. Tularemia: Potential role of cytopathology in differential diagnosis of cervical lymphadenitis: Multicenter experience in 53 cases and literature review. Apmis 2014, 122, 236–242. [Google Scholar] [CrossRef] [PubMed]
  26. Chrdle, A.; Tinavská, P.; Dvořáčková, O.; Filipová, P.; Hnetilová, V.; Žampach, P.; Batistová, K.; Chmelík, V.; Semper, A.E.; Beeching, N.J. Early Diagnosis of Tularemia by Flow Cytometry, Czech Republic, 2003–2015. Emerg. Infect. Dis. 2019, 25, 1919–1927. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Clinical course of the lymph node extirpation. (A) initial presentation; (B) upon transfer to our hospital; (C) one month after treatment with ciprofloxacin.
Figure 1. Clinical course of the lymph node extirpation. (A) initial presentation; (B) upon transfer to our hospital; (C) one month after treatment with ciprofloxacin.
Diagnostics 12 02000 g001
Table 1. Considered differential diagnoses, and their diagnostic approaches.
Table 1. Considered differential diagnoses, and their diagnostic approaches.
Differential DiagnosisDiagnostic ApproachSpecimenDetails
SarcoidosisChest X-ray Admitting clinic
Carcinoma metastasis, lymphomaCT scan of the neck Panendoscopic biopsy Admitting clinic
TuberculosisPanendoscopic biopsy
PCR
Ziehl–Neelsen stain
TBC culture
Abscess fluid; sputumXpert MTB/RIF Ultra, Cepheid, Krefeld, Germany;
solid and liquid culture (Löwenstein–Jensen agar (BD, Heidelberg, Germany), Stonebrink agar (Oxoid, Wesel, Germany), and MGIT (BD))
Interferon-gamma release assayLithium heparin bloodQuantiFERON IFN-γ Standard, Qiagen, Hilden, Germany
Atypical
mycobacteriosis
PCR
TB culture
Abscess fluid“In-house“-PCR Mycobacterium genus;
solid and liquid culture (Löwenstein–Jensen agar (BD), additionally incubated at 30 °C, Stonebrink agar (Oxoid), and MGIT (BD))
ToxoplasmosisELISA
PCR
Blood serum; abscess fluidSERION ELISA classic, Toxoplasma gondii IgG/IgM, Virion Serion, Würzburg, Germany;
ProGenie RealCycler TGON-U/TGON-G, Valencia, Spain
BartonellosisIIFT
PCR
Blood serum;
abscess fluid
Anti-Bartonella-henselae-IIFT (IgG and IgM), Euroimmun, Lübeck, Germany;
ProGenie RealCycler BART-U/BART-G
CryptococcosisCryptococcal antigen lateral flow assayAbscess fluidCrAg LFA, IMMY Inc., Norman, USA
ChlamydiosisPCRAbscess fluidChlamydia trachomatis PCR Kit, GeneProof a.s., Dolní Heršpice, Czech Republic
BrucellosisPCRAbscess fluidBactoReal Kit Brucella spp., Ingenetix, Vienna, Austria
Bacterial culturesAbscess fluidColumbia blood agar and Chocolate agar (incubated at 5% CO2 at 36 ± 1 °C for 48 h under aerobic conditions); thioglycolate broth (all BD); Schaedler KV selective agar (incubated under anaerobic conditions at 36 ± 1 °C; Oxoid)
(Eu-) bacteria PCRAbscess fluid(Eu-) bacteria domain, standard in-house PCR
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Boeckel, G.R.; Adiprasito, J.B.; Froböse, N.J.; Schaumburg, F.; Vollenberg, R.; Tepasse, P.-R. Tularemia Presenting Solely with Cervical Lymphadenopathy and Fever. Diagnostics 2022, 12, 2000. https://doi.org/10.3390/diagnostics12082000

AMA Style

Boeckel GR, Adiprasito JB, Froböse NJ, Schaumburg F, Vollenberg R, Tepasse P-R. Tularemia Presenting Solely with Cervical Lymphadenopathy and Fever. Diagnostics. 2022; 12(8):2000. https://doi.org/10.3390/diagnostics12082000

Chicago/Turabian Style

Boeckel, Göran Ramin, Jan Basri Adiprasito, Neele Judith Froböse, Frieder Schaumburg, Richard Vollenberg, and Phil-Robin Tepasse. 2022. "Tularemia Presenting Solely with Cervical Lymphadenopathy and Fever" Diagnostics 12, no. 8: 2000. https://doi.org/10.3390/diagnostics12082000

APA Style

Boeckel, G. R., Adiprasito, J. B., Froböse, N. J., Schaumburg, F., Vollenberg, R., & Tepasse, P. -R. (2022). Tularemia Presenting Solely with Cervical Lymphadenopathy and Fever. Diagnostics, 12(8), 2000. https://doi.org/10.3390/diagnostics12082000

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop